<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Tetracycline analogue-regulated transgene expression <br /> in Plasmodium falciparum blood stages using <br /> Toxoplasma gondii transactivators <br /> Markus Meissner&#226;&#8364;&#160;&#226;&#8364;&#161;&#194;&#167;&#194;&#182;, Efrosinia Krejany&#226;&#8364;&#160;&#194;&#182;, Paul R. Gilson&#226;&#8364;&#160;, Tania F. Koning-Ward&#226;&#8364;&#160;, Dominique Soldati&#226;&#8364;&#161;&#229;&#8218;&#168;, <br /> and Brendan S. Crabb&#226;&#8364;&#160;,&#226;&#8364;&#160;&#226;&#8364;&#160; <br /> &#226;&#8364;&#160;The Walter Eliza Hall Institute Medical Research, 1G Royal Parade, Parkville VIC 3050, Australia; &#226;&#8364;&#161;Department Biological Sciences, Imperial College <br />  <br /> of Science, Technology, Medicine, Imperial College Road, London SW7 2AZ, United Kingdom; &#194;&#167;Abteilung Parasitologie, Hygiene-Institut, <br /> Universita&#194;&#168;tsklinikum Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany <br />  <br /> Communicated Louis H. Miller, National Institutes Health, Rockville, MD, January 6, 2005 (received review November 16, 2004) <br />  <br /> Genetic manipulation revolutionized research Apicom-                  establishing anhydrotetracycline (ATc)-regulated gene ex- <br /> plexan parasite Plasmodium falciparum, important caus-                  pression systems Toxoplasma gondii, distant relative P. <br /> ative agent malaria. However, date techniques                 falciparum (5, 6). <br /> established allow modifications deleterious blood-                 The effective approaches developed T. <br /> stage growth, disruption essential genes                   gondii based Tet-transactivator system. In mammalian <br /> expression dominant-negative transgenes. The recent establish-                cells, uses fusion protein Tet repressor (TetR) <br /> ment screen functional transactivators related                   C-terminal transactivating domain herpes sim- <br /> parasite Toxoplasma gondii prompted identify transactiva-                  plex virus VP16 protein, process converts repressor <br /> tors T. gondii examine functionality P. falciparum.           efficient Tet-controlled transactivator (tTA) (7). Our <br /> Tetracycline-responsive minimal promoters generated based                   attempts adapt T. gondii failed tTA <br /> on characterized P. falciparum calmodulin promoter used                  capable activating minimal promoters derived <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> assess transactivators P. falciparum. We demonstrate                  organism (5). Therefore, genetic screen based random <br /> artificial tetracycline-regulated transactivators isolated T. gondii          insertion designed identify functional transcriptional <br /> are functional P. falciparum. By using tetracycline                  activating domain T. gondii establish ATc transac- <br /> analogue anhydrotetracycline, efficient, stage-specific gene regu-               tivator-based regulation system. This new permitted the <br /> lation achieved P. falciparum. This regulatable expression                creation conditional <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span>knockout</span> essential gene T. <br /> technology clear potential study essential gene                   gondii (6). <br /> function P. falciparum blood stages. On hand,                      Here, report reversible expression genes P. <br /> identified transactivators functional mammalian cells,                falciparum, using employs ATc-regulated <br /> consistent fundamental differences mechanism                  transactivators identified T. gondii activate P. falciparum <br /> gene regulation Apicomplexan parasites human                   minimal promoters. We observed &#226;&#172;&#381;50-fold regulation the <br /> hosts.                                                                           GFP reporter gene using ATc course single 48-h <br />                                                                                  growth cycle, 10- 20-fold regulation achieved <br /> Apicomplexa &#229;&#8230;&#169; transcription &#229;&#8230;&#169; gene regulation &#229;&#8230;&#169; anhydrotetracycline &#229;&#8230;&#169;            chloramphenicol acetyltransferase (CAT) reporter over <br /> inducible expression                                                             growth cycles. This broad applicability <br />                                                                                  analysis important gene functions P. falciparum <br />  <br /> P   lasmodium falciparum causative agent most <br />     severe form human malaria. In years, several <br /> powerful new tools strategies associated DNA trans- <br />                                                                                  blood stages. <br />  <br />                                                                                  Materials Methods <br /> formation developed clinically relevant blood                   Plasmids. The T. gondii TATi-2 expression plasmid generated <br /> stage organism (for reviews, refs. 1 2). However,                previously described pTTATi-1-HX (6) using poly(T) <br /> for number reasons, notably low efficiency                      primer BamHI restriction site 3&#226;&#172;&#732; end Rep-4 <br /> transfection (3), genetic manipulations slight                  (5&#226;&#172;&#732;-CGGA AT TCCT T T TCGACA A A ATGTCGCGCCTG- <br /> deleterious effect erythrocyte-stage growth                    GACAAGAGCAAAGTCATCAACTCTGC-3&#226;&#172;&#732;) primers for <br /> difficult perform. These include expression transgenes                 amplification. For generation plasmid allowing stable <br /> that negatively impact growth deletion genes play                expression TATi-3, oligonucleotides encoding transacti- <br /> a crucial role maintenance blood-stage cycle,                 vating domain generated (TATi-3-sense, 5&#226;&#172;&#732;-TTATCTC- <br /> especially problematic given haploid nature genome                    CTGCCAACGTGCATCCCTTAAT-3&#226;&#172;&#732;, TATi-3-as, 5&#226;&#172;&#732;- <br /> during stage. This technical deficiency major roadblock <br /> in functional analysis important blood-stage P. falciparum <br />                                                                                  Freely available online PNAS open access option. <br /> proteins, display potential drug blood- <br /> stage vaccine targets.                                                           Abbreviations: Tet, tetracycline; ATc, anhydrotetracycline; TetR, Tet repressor; tTA, Tet- <br />                                                                                  controlled transactivator; CAT, chloramphenicol acetyltransferase; TATi, transactivator of <br />    For eukaryotes, gene fulfills critical          Toxoplasma gondii; CAM, calmodulin; GPI, glycosylphosphatidylinositol. <br /> role <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span>survival</span>, targeted gene disruption replaced a <br />                                                                                  Data deposition: The sequence reported paper deposited GenBank <br /> knockdown approach. Use <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi)                           database (accession no. AY860671). <br /> specifically lower level mRNA consequently                     &#194;&#182;M.M.   E.K. contributed equally work. <br /> level corresponding protein. For part, however,                  &#229;&#8218;&#168;To correspondence sent present address: Department Microbiology <br /> RNAi-based approaches proved unsuccessful Apicom-                         Molecular Medicine, Faculty Medicine, University Geneva, Centre Medicale <br /> plexa possibly parasites lack key                       Universitaire, 1 Rue Michel-Servet, 1211 Geneva 4, Switzerland. E-mail: dominique.soldati- <br /> enzymes involved process (4). Another widely used                          favre@medecine.unige.ch. <br /> approach studying essential genes tetracycline (Tet)-                  &#226;&#8364;&#160;&#226;&#8364;&#160;To   correspondence addressed. E-mail: crabb@wehi.edu.au. <br /> based transcriptional regulation system. Recently, succeeded                  &#194;&#169; 2005 The National Academy Sciences USA <br />  <br />  <br />  <br /> 2980 &#226;&#8364;&#8220;2985 &#229;&#8230;&#169; PNAS &#229;&#8230;&#169; February 22, 2005 &#229;&#8230;&#169; vol. 102 &#229;&#8230;&#169; no. 8                                                            www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0500112102 <br />  TA AGGGGTACACT TGGGCAGGAGATA ATGCA-3&#226;&#172;&#732;),                           (5&#226;&#172;&#732;-TAAATCTCGAGGATCCTTAAGACCCACTT), the <br /> yielding double-stranded oligonucleotides NsiI- PacI-    resulting product inserted XhoI site pHH1 (11). <br /> compatible overhanging ends, allowing insertion corre- <br /> sponding sites pTetR-DHFRTS (6). In second step,         Parasites Transfection. Stable transformants T. gondii were <br /> DHFR-TS-selectable marker exchanged HXGPRT             derived described (12). The recipient strain p7TetOS1LacZ- <br /> SacII digestion. For expression TATi-1 TATi-2 HeLa      p7TetOS1HXGPRT-CAT described (6). For ran- <br /> cells, amplified respective genes using primers TATi-6     dom integration screening, 109 recipient parasites trans- <br /> (5&#226;&#172;&#732;-CCGGAATTCACCATGTCGCGCCTGGACAAGAGC-                            fected pTRep-DHFRTS selected resistance to <br /> 3&#226;&#172;&#732;) TATi-7 (5&#226;&#172;&#732;-CCGGGATCCCGGTGATTAATTA-                        pyrimethamine mycophenolic acid&#229;&#8230;&#190;xanthine ab- <br /> AGCGTTAATATTTTGTTAAAATTCGCG-3&#226;&#172;&#732;); used                      sence ATc (see ref. 6). TATi-1-, TATi-2-, TATi-3- <br /> PCR fragments generated replace tTA2s         expressing parasites obtained stable integration the <br /> vector pUHD16-3 using EcoRI BamHI, respectively. For       respective expression vector parasites lacking HXGPRT (RH- <br /> stable expression TATi-1 TATi-2 P. falciparum,       hxgprt). Positive clones examined transactivator expres- <br /> amplified gene using primers TATi-4 (5&#226;&#172;&#732;-CCGCTC-              sion Western blotting indirect immunofluorescence assay <br /> GAGAATGTCGCGCCTGGACAAGAGC-3&#226;&#172;&#732;) TATi-5                          (IFA) (data shown). Blood stages P. falciparum strain D10 <br /> (5&#226;&#172;&#732;-A ACCTAGGTGAT TA AT TA AGCGT TA ATAT T T T-                   cultivated synchronized described (13, 14). P. <br /> GTTAAAATTCGCG-3&#226;&#172;&#732;) inserted resulting PCR                 falciparum ring-stage parasites transiently stably trans- <br /> fragment XhoI AvrII sites vector pHHMI     fected 50&#226;&#8364;&#8220;100 &#226;?&#174;g purified plasmid DNA (Plasmid Maxi <br /> to produce pHH-TATi-1 pHH-TATi-2, respectively. CAT           Kit, Qiagen, Valencia, CA) modified electroporation <br /> reporter plasmids generated inserting HindIII&#226;&#8364;&#8220;SphI      conditions (2, 8, 15). HeLa cells (XL1.6) transiently <br /> PCR fragment encoding seven TetO sequences upstream        transfected described (16). <br /> minimal calmodulin (CAM) promoters constructs <br /> pCAM5.4&#229;&#8230;&#190;3, pCAM5.5&#229;&#8230;&#190;3, pCAM5.6&#229;&#8230;&#190;3 (8), resulting             Results <br /> plasmids pTOCAM5.4&#229;&#8230;&#190;3, pTOCAM5.5&#229;&#8230;&#190;3, pTOCAM5.6&#229;&#8230;&#190;3. <br />  <br />  <br />  <br />  <br />                                                                                                                                          MICROBIOLOGY <br />                                                                   Isolation Characterization Functional Transactivators T. <br />    To create constructs generation parasites stably    gondii. Recently, described insertion mutagenesis ap- <br /> expressing TATi-1 TATi-2 regulatable CAT reporter      proach identifying functional transactivating domains T. <br /> gene, PCR fragments encoding seven TetO minimal CAM           gondii integrating random linear DNA fragment encoding <br /> promoters pTOCAM5.4&#229;&#8230;&#190;3 pTOCAM5.6&#229;&#8230;&#190;3 inserted             resistance marker gene TetR stop codon <br /> into NotI sites pHH-TATi-1 pHH-TATi-2. The primers      genome recipient strain T. gondii (6). This strain <br /> used Tet-s (5&#226;&#172;&#732;-AAGCGGCCGCTTTCGATACCGTC-                      includes reporter gene (LacZ) selectable marker gene <br /> GACCTCGAGTTTAC-3&#226;&#172;&#732;) CAM-as (5&#226;&#172;&#732;-AAGCGGCCG-                      (HXGPRT) control TetO-minimal promoter <br /> CATCGATA ACTGCAGCTGGCGATCCTGATATAT T-                             (p7TetOS1). This genetic screen led isolation a <br /> TCTATTAGG-3&#226;&#172;&#732;). KpnI-digested DNA fragments pTO-              functional TetR transactivator, termed TATi-1 (6). Using the <br /> CAM5.4&#229;&#8230;&#190;3 pTOCAM5.6&#229;&#8230;&#190;3 encoding respective mini-            strategy here, isolated second transactivator, termed <br /> mal CAM promoters CAT reporter introduced           TATi-2. Surprisingly, sequence TATi-2 matched almost <br /> pTO5.6&#229;&#8230;&#190;TATi-2. This generated plasmids pTC5.4&#229;&#8230;&#190;TATi-1,         perfectly TATi-1, indicating insertion had <br /> pTC5.6&#229;&#8230;&#190;TATi-1, pTC5.4&#229;&#8230;&#190;TATi-2, pTC5.6&#229;&#8230;&#190;TATi-2.                  occurred locus. Further analysis DNA <br />    To construct pTGPI-GFP, 5&#226;&#172;&#732; 3&#226;&#172;&#732; ends EGFP        sequence showed integration random through- <br /> flanked sequence encoding signal peptide     T. gondii genome anticipated had <br /> glycosylphosphatidylinositol (GPI)-anchor signal P. falcipa-   occurred plasmid backbone previously inte- <br /> rum MSP-1, respectively, using MSP-1ss (5&#226;&#172;&#732;-AGGATCGCT-          grated plasmids (data shown). However, sequence of <br /> GCAGGTCAAAATGAAGATCATATTCTTTTTATGT-3&#226;&#172;&#732;                             TATi-2 different TATi-1; difference to <br /> and 5&#226;&#172;&#732;-GT TCT TCTCCT T TACTCAT T TCATGTGT TAC-                    integration different positions, resulting shorter TetR <br /> ACATTGTGTA-3&#226;&#172;&#732;), EGFP (5&#226;&#172;&#732;-TACACAATGTGTAACAC-                       fusion protein (Fig. 1A). Note TATi-1 TATi-2, the <br /> ATGAAATGAGTAAAGGAGAAGAAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-TCCG-                          short C-terminal deletions observed TetR predicted to <br /> GAAGAACTACAGAATACAATTGCTTTTAAATC ACT-                             influence DNA binding induction Tet (17). Hence, TATi-1 <br /> 3&#226;&#172;&#732;), MSP-1gs (5&#226;&#172;&#732;-AGTGATTTAAAAGCAATTGTAT-                      TATi-2 considered artificial (not endogenous) T. <br /> TCTGTAGT TCT TCCGGA-3&#226;&#172;&#732; 5&#226;&#172;&#732;-TGA AGA AACT-                       gondii transactivators. <br /> AGTTTAAAATAAATTAAATAC-3&#226;&#172;&#732;) primers PCRs. The                       Although primary sequences TATi-1 TATi-2 differ, <br /> products sewn subsequent rounds PCR      amino acid composition transactivating domains is <br /> to produce GPI&#226;&#8364;&#8220;GFP fragment. A PCR fragment comprising          similar, having predominance hydrophobic and <br /> the CAM 3&#226;&#172;&#732; UTR (8) amplified using primers             polar residues (Fig. 1B). A screen artificial transactivating <br /> 5&#226;&#172;&#732;-GCAGAACTGCAGCGTATTATATTACTAGTTTTTA-                            domains yeast retrieved transactivator (referred as <br /> AATATGCAGA-3&#226;&#172;&#732; 5&#226;&#172;&#732;-GATTCGATCGATCACTTA-                          TATi-3) minimal transactivating domain eight <br /> ATAAAAAAGAGGA-3&#226;&#172;&#732;, digested PstI ClaI,                amino acids (18). As TATi-1 TATi-2, sequences of <br /> ligated downstream CAM minimal promoter             transactivating domains relatively hydrophobic and <br /> intermediate vector pTO5.6&#229;&#8230;&#190;TATi-2 (see above). This new           polar. On hand, minimal transactivating domain <br /> plasmid digested PstI SpeI GPI&#226;&#8364;&#8220;GFP      present tTA, functional T. gondii, highly <br /> fragment ligated CAM minimal promoter         acidic contains polar amino acids (Fig. 1B). <br /> 3&#226;&#172;&#732; UTR. The HSP86 promoter driving TATi-2 expression             To compare strength artificial transactivating <br /> excised replaced MSP-2 promoter (9) BglII    domains, TATi-1, TATi-2, TATi-3 stably expressed in <br /> XhoI sites. Finally, BglII fragment comprising Rep-20       T. gondii tachyzoites tested ability transactivate <br /> repeat sequence (3) inserted BglII site    minimal Tet-responsive promoter (6). As expected, original <br /> MSP-2 CAM promoters controlling expression human       tTA (7) did transactivate TetO-minimal promoter T. <br /> dihydrofolate reductase (hDHFR). To generate pHH&#229;&#8230;&#190;TetR,        gondii, TATi-1 TATi-2 demonstrated strong trans- <br /> complete TetR sequence amplified PCR pHD360           activating capacity parasite (Fig. 1C). ATc reversed the <br /> (10) using oligonucleotides TetR.For (5&#226;&#172;&#732;-CGAAGCTC-         transactivation TATi-1 TATi-2; however, back- <br /> GAGTATGTCAAGATTAGATAAAAGTA) TetR.Rev                          ground activity substantially higher case TATi-2 <br />  <br /> Meissner et al.                                                                     PNAS &#229;&#8230;&#169; February 22, 2005 &#229;&#8230;&#169; vol. 102 &#229;&#8230;&#169; no. 8 &#229;&#8230;&#169; 2981 <br />                                                                                     Fig. 2. Functional expression TATi-1 TATi-2 P. falciparum analyzed <br />                                                                                    transient transfection. (A) Schematic diagram expression vectors <br />                                                                                    used generate drug-resistant P. falciparum (D10 line) transfectants express- <br />                                                                                    ing TATi-1 TATi-2. (B) Western blot analysis parasites expressing <br />                                                                                    TATi-1 TATi-2 and, control, TetR protein. (C) Quantification CAT <br />                                                                                    activity parasites transiently transfected reporter constructs contain- <br />                                                                                    ing minimal CAM promoters different lengths flanked upstream seven <br />                                                                                    TetO sequences full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> CAM promoter (pCAM5&#229;&#8230;&#190;3; ref. 8). Black <br /> Fig. 1. Functional transactivators T. gondii. (A) An alignment           boxes represent previously defined promoter elements (8). D10-TATi-2 para- <br /> transactivating domains (boxed) compared C terminus TetR. The          sites incubated 48 h presence absence ATc transient <br /> italicized residues arose introduced restriction site. (B) Amino acid      transfection reporter plasmids. Data independent exper- <br /> composition transactivating domains. The percentages acidic (DE), basic      iments. (D) Measurement promoter activity presence different ATc <br /> (KR), charged (RKHYCDE), polar (NCQSTY), hydrophobic (AILFWY) amino            concentrations analyzed transient conditions above. In instance <br /> acids transactivation domains tTA, TATi-1, TATi-2, TATi-3       pCAM5.1&#229;&#8230;&#190;3 plasmid used positive control (8). <br /> determined using PROTEAN program (DNASTAR, Madison, WI). (C) T. <br /> gondii transactivators different efficiencies. T. gondii parasites express- <br /> ing tTA, TATi-1, TATi-2, TATi-3 transiently transfected           T. gondii genetic screen capable interacting factors <br /> reporter plasmid T7S1LacZ-CAT incubated presence absence          conserved higher eukaryotic transcription machinery, TATi-1 <br /> ATc &#226;&#172;&#8225;48 h. A summary independent experiments shown. (D) T.         TATi-2 tested ability transactivate the <br /> gondii transactivators functional HeLa cells. The HeLa line XL1&#229;&#8230;&#190;6,      Tet-responsive minimal promoter, PhCMV*-1 (7) HeLa cells. <br /> which contains gene luciferase control target pro- <br />                                                                                    Under transient transfection conditions, stimulation pro- <br /> moter PhCMV* (7), transiently transfected expression plasmids tTA, <br /> TATi-1, TATi-2. Cells grown 24 h presence absence of <br />                                                                                    moter activity detectable TATi-1 TATi-2, <br /> doxycycline (Dox) luciferase LacZ (as internal standard) expres-     tTA allowed gene regulation &#226;&#172;&#381;5 orders of <br /> sion determined. A summary independent experiments shown.          magnitude (Fig. 1D). This result suggests TATi-1 and <br />                                                                                    TATi-2 interact transcription factors present in <br />                                                                                    higher eukaryotes. Similarly, transactivating domain of <br /> (Fig. 1C). Unexpectedly, TATi-3 allowed activa-                      TATi-3, originally identified yeast, active in <br /> tion reporter gene presence ATc,                     mammalian cells (18). <br /> background activity detected absence ATc (Fig. <br /> 1C). One significant difference amino acid composition                   TATi-1 TATi-2 Act Functional Transactivators P. falciparum. <br /> TATi-3 high portion charged amino acids (Fig. 1B). We                    To determine T. gondii transactivators functioned in <br /> therefore speculate unique characteristics TATi-3                  P. falciparum, generated constructs TATi-1 or <br /> transactivating domain modify TetR binding properties, render-                     TATi-2 placed control P. falciparum HSP86 <br /> ing activator reversed DNA-binding activity.                       promoter (Fig. 2A). After selection episomal maintenance of <br /> Similar transactivators identified previously (19).                      plasmid obtained transgenic parasite lines expressing <br />    To determine activating domains identified                   TATi-1 TATi-2 (Fig. 2B). The strong expression of <br />  <br /> 2982 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0500112102                                                                                                 Meissner et al. <br />                                                                                                                                                                         MICROBIOLOGY <br /> Fig. 3. Transactivation regulation promoter activity stably transfected P. falciparum. (A) Stable induction CAT control inducible <br /> minimal promoters. Parasites stably transfected plasmid constructs designed express TATi transactivators CAT control particular <br /> regulatable CAM minimal promoters assayed CAT activity. The elements controlling transcription TATi proteins hDHFR plasmids were <br /> the Fig. 2 A. Results expressed relative CAT activity previously described CAT-expressing line, D10-HC1&#229;&#8230;&#190;CAT (20), analyzed parallel. <br /> (B) Regulation stable transgenic P. falciparum lines ATc. On day 0, identical cultures split groups, termed &#226;&#8364;&#732;&#226;&#8364;&#732;sample A&#226;&#8364;&#8482;&#226;&#8364;&#8482; &#226;&#8364;&#732;&#226;&#8364;&#732;sample B.&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> Sample A cultures maintained absence ATc 4 days (two growth cycles), sample B parasites grown presence 0.5 &#226;?&#174;g&#229;&#8230;&#190;ml <br /> ATc period. Results expressed percentage ratio CAT activity sample B sample A. (C) D10-HC1&#229;&#8230;&#190;CAT D10-TC5.6&#229;&#8230;&#190;TATi-2 parasites <br /> were subjected ATc regulation described above, sample B maintained presence ATc day 6, time ATc removed. <br /> Each data point mean (&#226;&#171;&#190;SD) values linear range independent experiments. <br />  <br />  <br />  <br /> these transactivators surprising                            promoter constructs activated degree the <br /> achieved similar stable expression P. falciparum TetR (Fig.                   TATi-2 transient conditions. <br /> 2B) number TetR mutants using similar approaches <br /> (data shown). Moreover, despite extreme AT bias P.                       Establishment ATc-Regulated-Expression System P. falcipa- <br /> falciparum, codons transactivators opti-                      rum. Because Tet derivatives toxic P. <br /> mized P. falciparum, optimization proven                   falciparum, used ATc regulate TATi-induced transactiva- <br /> to necessary strong expression GC-rich transgenes                      tion. As evidenced study (see below), ATc not <br /> this organism (20&#226;&#8364;&#8220;22).                                                              toxic P. falciparum levels 0.5&#226;&#8364;&#8220;1.0 &#226;?&#174;g&#229;&#8230;&#190;ml, over <br />    To monitor promoter activation TATi-1 TATi-2,                           longer-term continuous culture (&#226;&#172;&#8225;1 month). Under transient <br /> generated ATc-responsive promoters based previously de-                          conditions, CAT expression parasites transfected a <br /> scribed CAM-minimal promoters fused seven TetO sequences                         control construct encoding CAT transcriptional control of <br /> (Fig. 2C). CAT activity monitored 48 h transient                          length CAM promoter (pCAM5&#229;&#8230;&#190;3) affected by <br /> transfection constructs parental parasites par-                    presence ATc. In contrast, ATc-responsive minimal <br /> asites expressing TATi-1 TATi-2. In preliminary experi-                        promoter plasmids showed clear difference CAT activity <br /> ment, observed that, transfection wild-type                         noninduced induced states (Fig. 2C). We <br /> control parasites yielded little expression minimal                        established ATc concentrations low 0.1 &#226;?&#174;g&#229;&#8230;&#190;ml <br /> promoters, substantial activation CAT expression                    achieved similar levels regulation (Fig. 2D). <br /> parasites expressing TATi-2 small degree activation                        To test efficiency transactivation parasites stably <br /> parasites expressing TATi-1 (data shown). We noticed                       transfected ATc-responsive promoters, generated <br /> expression TATi-1 diminished persistent mainte-                        constructs containing expression cassette TATi-1 or <br /> nance parasites selection (data shown). Hence,                     TATi-2 CAT reporter gene control <br /> the discrepancy activation TATi-1 TATi-2                         ATc-responsive promoters pTOCAM5.4&#229;&#8230;&#190;3 or <br /> be explained reduced expression level TATi-1. In view                     pTOCAM5.6&#229;&#8230;&#190;3 (Fig. 3A). Substantial promoter activation was <br /> of loss expression TATi-1, transient transfections                   observed parasites transfected pTC5.6&#229;&#8230;&#190;TATi-2, reaching <br /> with TATi-2-expressing parasites repeated, cumu-                       30% CAT activity compared parasites trans- <br /> lative results presented Fig. 2C. All minimal                          fected positive control plasmid pHC1&#229;&#8230;&#190;CAT (20). Rel- <br />  <br /> Meissner et al.                                                                                          PNAS &#229;&#8230;&#169; February 22, 2005 &#229;&#8230;&#169; vol. 102 &#229;&#8230;&#169; no. 8 &#229;&#8230;&#169; 2983 <br />  atively weaker promoter activation seen combi- <br /> nations transactivator minimal promoter (Fig. 3A). The <br /> high degree variation different reporter constructs <br /> may explained different levels TATi-1 TATi-2 <br /> expression different lines (data shown). <br />    We compared CAT activities growth parasite <br /> cycles presence absence ATc parasite lines <br /> D10-TC5.4&#229;&#8230;&#190;TATi-1, D10-TC5.6&#229;&#8230;&#190;TATi-2, D10-HC1&#229;&#8230;&#190;CAT. <br /> In regulatable parasite lines, significant reduction (10- to <br /> 20-fold) CAT activity evident presence ATc <br /> relative identical cultures grown parallel absence of <br /> ATc, difference CAT activity observed in <br /> positive control parasite D10-HC1&#229;&#8230;&#190;CAT presence or <br /> absence ATc (Fig. 3B). <br />    Time course experiments performed using D10- <br /> TC5.6&#229;&#8230;&#190;TATi-2 line, consistently demonstrated the <br /> best regulation (Fig. 3C). After 2 days presence ATc, <br /> CAT activity significantly reduced, reaching baseline activity <br /> after 4 days incubation. On day 6, ATc removed, resulting <br /> in reactivation regulatable promoter maximal <br /> expression level 6 days incubation. The absence <br /> of ATc effect expression CAT control <br /> D10-HC1&#229;&#8230;&#190;CAT line shows ATc toxic effect P. <br /> falciparum concentration (Fig. 3C). <br />    To better examine regulation validate system, <br /> we inserted GFP control ATc-regulatable <br /> promoter pTOCAM5.6&#229;&#8230;&#190;3. In attempt maximize the <br /> prospects rapid turnover reporter, GFP gene was <br /> fused sequence encoding N-terminal signal peptide a <br />                                                                      Fig. 4. Inducible stage-specific expression GFP fusion protein P. <br /> C-terminal GPI addition sequence. The resulting construct            falciparum. (A) Diagram pTGPI-GFP plasmid containing necessary <br /> allows ATc-regulated expression GFP stage-specific            elements including selectable marker (hDHFR) full-length CAM <br /> expression TATi-2 control MSP-2 promoter         promoter, transactivator (TATi-2), GPI&#226;&#8364;&#8220;GFP cassettes, controlled <br /> (9) (Fig. 4A). Because observed transgenes         Tet-responsive promoter. TATi-2 control MSP-2 <br /> encoding GPI-anchored proteins toxic P. falcipa-       promoter (M5&#226;&#172;&#732;; ref. 9) Rep-20 element (3). This plasmid stably <br /> rum (R. A. O&#226;&#8364;&#8482;Donnell B.S.C., unpublished data), line        transformed D10 parasites continual presence ATc. (B) Assessment <br /> was maintained presence 0.5 &#226;?&#174;g&#229;&#8230;&#190;ml ATc              ATc regulation. A culture transformed parasites maintained the <br /> duration selection period transfection (3&#226;&#8364;&#8220;4 weeks).     absence ATc split identical cultures maintained the <br />                                                                      absence presence ATc growth cycle. Lanes 1&#226;&#8364;&#8220; 6 represent 8-h <br /> After drug-resistant line established, ATc removed <br />                                                                      time points synchronized ring-stages analyzed Western blotting and <br /> from medium, resulting presence fluorescent            probing antibodies HSP70, MSP-2, GFP. (C) GFP fluorescence <br /> parasites &#226;&#172;&#8225;20% population. The activated (i.e.,    schizont-stage parasites. Parallel cultures parasites maintained <br /> ATc) line synchronized separated identical          presence absence ATc isolated uninfected red blood <br /> cultures. ATc added cultures, samples     cells microscopy. Phase, phase contrast. <br /> taken cultures ATc 48-h <br /> period. Using Western blotting fluorescence micro- <br /> scopic analysis, confirmed GFP effectively spe-       function elements stably inte- <br /> cifically down-regulated addition ATc undetectable       grated genome. Nevertheless, lack success date <br /> levels single parasite cycle (Fig. 4 B C). Using      approach, uncertainty surrounding <br /> limiting-dilution Western blot approach, estimated     potential RNA interference (RNAi) organism, led <br /> &#226;&#172;&#381;50-fold regulation. No difference expression level           explore possibility ATc-regulated transactivators <br /> observed endogenous protein MSP-2 heat shock              functional T. gondii function P. falciparum. <br /> protein HSP70 (Fig. 4C). Importantly, timing induced         TATi-1 TATi-2 obtained random insertion- <br /> GFP life cycle similar       based genetic screen T. gondii. It eventuated insertion <br /> schizont-stage protein MSP-2, promoter drives       T. gondii line random: rather, integration into <br /> transactivator TATi-2 line.                                  preexisting plasmid backbone (in different reading frames) <br />                                                                      favored. Hence, transactivating domains TATi-1 and <br /> Discussion                                                           TATi-2 correspond parasite proteins instead <br /> Methods modulate gene expression P. falciparum blood           essentially adventitiously derived polypeptides com- <br /> stages required analysis gene function        mon predominantly hydrophobic amino acid composition and <br /> organism. Our group, example, focused devel-          absence charged amino acids. It presumably general <br /> oping direct TetR-regulated endogenously            characteristics provide transactivating capacity TetR- <br /> expressed TetR intended reversibly inactivate full-length      fusion protein. In contrast, transactivating domain tTA, <br /> parasite promoters binding Tet operators placed close       strong transactivator used Tet-regulated expression in <br /> proximity transcriptional start sites. Despite achieving strong   higher eukaryotes, highly acidic. In HeLa cells, TATi-1 <br /> stable expression wild-type mutant TetR             TATi-2 inactive, suggesting fundamental differences in <br /> different P. falciparum promoters, did observe repression     transcription machinery T. gondii host. <br /> in different TetO-containing HSP86 MSP-2 pro-          Consistent hypothesis, bioinformatics approach re- <br /> moter constructs using transient transfection approach        vealed basic transcription machinery Apicomplexan <br /> (T.F.d.K.-W. B.S.C., unpublished data). It possible      parasites contains minimal set general transcription <br />  <br /> 2984 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0500112102                                                                                   Meissner et al. <br />  factors including TBP, TFB (a homologue TFIIB), TFE                             eliminate heterogeneity latter. The fact <br /> (a homologue TFIIE-&#226;?&#163;) resembles RNA polymerase                              expression profile GFP perfectly mimics steady- <br /> system Archaea (M.M. D.S., unpublished observations).                           state level MSP-2 entire erythrocytic cycle suggests <br />    TATi-1 TATi-2 function ATc-responsive transactiva-                           TATi-2 transcript protein rapidly turned the <br /> tors range ATc shows toxicity effects                       parasites. Therefore, regulation TATi-2 expression a <br /> blood stages P. falciparum. TATi-2 tolerated                          stage-specific promoter imposes second level control the <br /> expressed P. falciparum capable regulating CAT                         activity regulatable promoter addition modulation by <br /> reporter 10- 20-fold GFP reporter factor                           ATc. This considerable parasite the <br /> &#226;&#172;&#381;50-fold stable lines. Using GFP, demonstrated                              expression individual gene carefully induced <br /> inactivation gene expression rapid occurs single                    required. <br /> cycle addition ATc. Such rapid regulation                                 As stands, considerable potential the <br /> observed CAT growth cycles required                             analysis blood-stage gene function P. falciparum. Because <br /> maximally suppress expression. It likely primary                           inability observe transgene expression transiently <br /> reason slower regulation higher background                          (except using sensitive reporters) long time <br /> presence ATc seen bacterial CAT related                              period initial transfection analysis case of <br /> stability enzyme. The stability CAT result                       stable transformants (usually 1&#226;&#8364;&#8220;2 months), strong expression <br /> in carryover preexisting enzyme growth cycle                          transgenes particularly problematic organism, espe- <br /> (resulting slower regulation) accumulation small                      cially transgene impacts negatively growth. <br /> amounts CAT parasites maintained presence ATc                          Hence, ATc-regulation described have <br /> as result expected minimal promoter activity                          immediate practical value stage-specific expression trans- <br /> circumstance (resulting higher bac <br /> </body></html>